The Cooper Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The Cooper Health System sits in the top decile of US sponsors by registered trial count (#442 of 15,742 sponsors by registered trial count).
The Cooper Health System: 39 sponsored US clinical trials, 9 recruiting.
The Cooper Health System sponsors 39 registered US clinical trials on ClinicalTrials.gov, 9 of them currently recruiting, and 19 completed. 11 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Lung Cancer, with 2 trials.
Top-decile sponsor footprint
The Cooper Health System ranks in the top decile of sponsors by registered trial count (#442 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
19 of 26 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
39 total, page 1 of 1
Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department
NCT07430345
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
NCT06688422
Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection
NCT06510582
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
NCT07142408
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
NCT05203328
Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures
NCT06133920
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
NCT05719246
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
NCT03906617
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
NCT02749474
Emulated Study of Vitamin D Correction Vs Non-Correction
NCT06366776
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
NCT03092011
RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients
NCT07296120
Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization
NCT07042048
Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1
NCT06462781
Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
NCT04552886
Pre-consultation Compassion Among Patients Referred to a Cancer Center
NCT04503681
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
NCT04596657
ACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life
NCT05731557
Peri-procedural Smoking Cessation Program in Patients With Chronic Pain
NCT04605744
Does Early Elbow Motion Improve Patient Outcomes After Surgically Treated Elbow Fractures?
NCT05980312
Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques
NCT03996148
Caretaker vs. Routine Blood Pressure Sphygmomanometer
NCT03918486
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
NCT02933060
A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease
NCT03034564
Reoxygenation After Cardiac Arrest II (REOX II Study)
NCT02698826
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
NCT02707328
Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
NCT02641561
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
NCT02134366
Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
NCT02235064
Observation for Patients With Asymptomatic CNS Metastatic Disease
NCT02866981
Reoxygenation After Cardiac Arrest (REOX Study)
NCT01881243
Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients
NCT01011426
Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery
NCT00848991
Pain Relief for Ventilated Patients With Multiple Rib Fractures Using the ON-Q Pain Relief System
NCT00880529
Dexmedetomidine vs. Propofol for Cataract Surgery
NCT00786370
Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy
NCT00683189
Use of Dexmedetomidine for Sedation During Flexible Bronchoscopy in Patients With COPD: A Descriptive Study
NCT00401206
Betamethasone Dosing Interval - 12 or 24 Hours?
NCT00453141
Use of Intrapartum Biophysical Profile When Fetal Heart Rate Monitoring is Non-reassuring in Labor
NCT00454012
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 3 |
| Phase 3 | 4 |
| Phase 4 | 7 |
Therapeutic Areas
What is open in the The Cooper Health System pipeline
9 recruiting of 39 indexed (23% open); 19 completed (49%).
Phase mix: 11 late (III/IV) vs 9 early (I/II) (balanced across stages).
Top condition: Lung Cancer (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The Cooper Health System: open-pipeline peers nationwide
Peers matched on 39 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
The Cooper Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 39 trials (± recruiting share)
- Ethicon Endo-Surgery · 39 trials · 3% recruiting
- James J. Peters Veterans Affairs Medical Center · 39 trials · 10% recruiting
- Maimonides Medical Center · 39 trials · 15% recruiting
- Northeastern University · 39 trials · 38% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this The Cooper Health System page
39 registered trials is a research-attention snapshot, not an endorsement of The Cooper Health System or any single study.
- 9 of The Cooper Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lung Cancer is the condition The Cooper Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lung Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The Cooper Health System pipeline card: 39 registered trials from official public datasets.Report a data error.